Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-25 @ 3:56 AM
NCT ID:
NCT01922102
Eligibility Criteria:
Inclusion Criteria:
* Visual impairment due to CNV secondary to PM.
* Best corrected visual acuity in the study eye \> 24 and \< 78 ETDRS letters.
* High myopia (\> -6D),
* anterio-posterior elongation \> 26 mm; posterior changes compatible with the pathologic myopia.
* Either CNV locations in the study eye: subfoveal, juxtafoveal, extrafoveal.
Exclusion Criteria:
* Some preexisting eye disorders or systemic diseases;-Blood pressure \> 150/90 mmHg
* Prior focal/grid laser to the macular area -History of treatment with any anti-VEGF or verteporfin PDT in the study eye
* Intravitreal treatment with corticosteroids or intraocular surgery within last 3 months in the study eye
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01922102
Study Brief:
Protocol Section:
NCT01922102